Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A02963 | 34183373 | Diabetes | Deletion of the Feeding-Induced Hepatokine TSK Ameliorates the Melanocortin Obesity Syndrome. | 2021 | Details |
A02966 | 34182070 | Free Radic Biol Med | Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study. | 2021 | Details |
A02971 | 34178902 | Front Pediatr | Relationship Between Histological Features of Non-alcoholic Fatty Liver Disease and Ectopic Fat on Magnetic Resonance Imaging in Children and Adolescents. | 2021 | Details |
A02972 | 34178303 | J Surg Case Rep | Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case report. | 2021 | Details |
A02973 | 34177920 | Front Immunol | Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides. | 2021 | Details |
A02975 | 34176541 | Br J Nutr | Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. | 2021 | Details |
A02983 | 34174062 | J Gastrointestin Liver Dis | The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A02993 | 34171462 | Biochim Biophys Acta Gene Regul Mech | Polymorphisms rs55710213 and rs56334587 regulate SCD1 expression by modulating HNF4A binding. | 2021 | Details |
A02994 | 34171418 | Food Chem Toxicol | Palmitoyl-CoA effect on cytochrome c release, a key process of apoptosis, from liver mitochondria of rat with sucrose diet-induced obesity. | 2021 | Details |
A02995 | 34171397 | J Ethnopharmacol | Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway. | 2021 | Details |
A02996 | 34171051 | Rom J Morphol Embryol | Pediatric nonalcoholic fatty liver disease - a changing diagnostic paradigm. | 2021 | Details |
A03000 | 34169247 | JHEP Rep | Hepatic microbiome in healthy lean and obese humans. | 2021 | Details |
A03001 | 34168615 | Front Endocrinol (Lausanne) | Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome. | 2021 | Details |
A03004 | 34168277 | Int J Obes (Lond) | Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity. | 2021 | Details |
A03005 | 34168043 | BMJ Open Gastroenterol | Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
A03006 | 34167531 | BMC Surg | Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study. | 2021 | Details |
A03008 | 34165645 | J Med Ultrason (2001) | Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease. | 2021 | Details |
A03015 | 34163108 | World J Gastroenterol | Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. | 2021 | Details |
A03016 | 34162924 | Sci Rep | Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation. | 2021 | Details |
A03033 | 34156590 | Dig Dis Sci | A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A03037 | 34155821 | Pediatr Obes | Elevated transaminases potentiate the risk for emerging dysglycemia in children with overweight and obesity. | 2021 | Details |
A03038 | 34155801 | Liver Int | Management of NAFLD patients with advanced fibrosis. | 2021 | Details |
A03039 | 34155799 | Liver Int | Current management of NAFLD/NASH. | 2021 | Details |
A03040 | 34155798 | Liver Int | Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity? | 2021 | Details |
A03041 | 34155794 | Liver Int | New drugs for NASH. | 2021 | Details |
A03043 | 34155789 | Liver Int | COVID-19 and the liver - Lessons learned. | 2021 | Details |
A03067 | 34144391 | Redox Biol | Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules. | 2021 | Details |
A03070 | 34142516 | J Pediatr Endocrinol Metab | Evaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis. | 2021 | Details |
A03074 | 34141776 | World J Clin Cases | Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. | 2021 | Details |
A03075 | 34141709 | Front Cell Dev Biol | New Insights Into the Role of Autophagy in Liver Surgery in the Setting of Metabolic Syndrome and Related Diseases. | 2021 | Details |
A03078 | 34139486 | ESMO Open | Cancer and hepatic steatosis. | 2021 | Details |
A03085 | 34136549 | Front Cardiovasc Med | The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients. | 2021 | Details |
A03088 | 34136163 | Food Sci Nutr | Effects of several tea extracts on nonalcoholic fatty liver disease in mice fed with a high-fat diet. | 2021 | Details |
A03093 | 34134495 | Cas Lek Cesk | Non-alcoholic fatty liver disease - how to effectively fight the nowadays most common liver disease? | 2021 | Details |
A03100 | 34131333 | Nat Rev Endocrinol | Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. | 2021 | Details |
A03110 | 34126247 | Endocr Pract | High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency. | 2021 | Details |
A03113 | 34125886 | J Clin Endocrinol Metab | New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease. | 2021 | Details |
A03114 | 34125646 | Gut Microbes | Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. | 2021 | Details |
A03116 | 34124059 | Front Cell Dev Biol | Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review. | 2021 | Details |
A03123 | 34120339 | Eur J Clin Invest | Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort. | 2021 | Details |
A03127 | 34119629 | J Nutr Biochem | Sugar kelp (Saccharina latissima) inhibits hepatic inflammation and fibrosis in a mouse model of diet-induced nonalcoholic steatohepatitis. | 2021 | Details |
A03131 | 34118476 | Mol Metab | Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH. | 2021 | Details |
A03132 | 34118361 | Peptides | A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis. | 2021 | Details |
A03136 | 34118015 | Updates Surg | Liver transplantation and bariatric surgery: a new surgical reality: a systematic review of the best time for bariatric surgery. | 2021 | Details |
A03146 | 34114325 | EMBO Rep | SCFJFK is functionally linked to obesity and metabolic syndrome. | 2021 | Details |
A03147 | 34113839 | JHEP Rep | Evaluating causality of cellular senescence in non-alcoholic fatty liver disease. | 2021 | Details |
A03152 | 34112075 | Kardiologiia | Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. | 2021 | Details |
A03157 | 34107897 | BMC Pediatr | Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study. | 2021 | Details |
A03163 | 34106786 | Am J Physiol Cell Physiol | Impaired Ca2+ signaling due to hepatic steatosis mediates hepatic insulin resistance in Alström syndrome mice that is reversed by GLP-1 analog treatment. | 2021 | Details |
A03166 | 34106515 | Clin Obes | A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease. | 2021 | Details |
A03172 | 34103552 | Sci Rep | Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico. | 2021 | Details |
A03175 | 34100658 | Clin Pediatr (Phila) | Serum Alanine Transaminase Is an Inadequate Nonalcoholic Fatty Liver Screening Test in Adolescents: Results From the National Health and Nutrition Examination Survey 2017-2018. | 2021 | Details |
A03176 | 34099626 | Nutr Diabetes | Aging mitigates the severity of obesity-associated metabolic sequelae in a gender independent manner. | 2021 | Details |
A03181 | 34097961 | Int J Biol Macromol | A homogeneous polysaccharide from Lycium barbarum: Structural characterizations, anti-obesity effects and impacts on gut microbiota. | 2021 | Details |
A03183 | 34096925 | J Vis Exp | A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium. | 2021 | Details |
A03186 | 34095739 | J Pancreat Cancer | Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis. | 2021 | Details |
A03190 | 34095164 | Front Med (Lausanne) | Age and Interleukin-15 Levels Are Independently Associated With Intima-Media Thickness in Obesity-Related NAFLD Patients. | 2021 | Details |
A03202 | 34091530 | Chin Med J (Engl) | Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016. | 2021 | Details |
A03203 | 34091049 | Clin Gastroenterol Hepatol | A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores. | 2021 | Details |
A03211 | 34088709 | BMJ Open | Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests. | 2021 | Details |
A03219 | 34083525 | Nat Commun | Perilipin 5 links mitochondrial uncoupled respiration in brown fat to healthy white fat remodeling and systemic glucose tolerance. | 2021 | Details |
A03224 | 34081733 | PLoS One | Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018. | 2021 | Details |
A03225 | 34081362 | J Intern Med | Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients. | 2021 | Details |
A03231 | 34078528 | BMB Rep | Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway. | 2021 | Details |
A03235 | 34077443 | PLoS One | Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes. | 2021 | Details |
A03242 | 34074100 | Vnitr Lek | Rheumatoid arthritis and metabolic disorders. | 2021 | Details |
A03244 | 34073883 | J Clin Med | Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs. | 2021 | Details |
A03245 | 34073834 | Int J Mol Sci | P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice. | 2021 | Details |
A03246 | 34072995 | Metabolites | Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review. | 2021 | Details |
A03250 | 34072137 | Nutrients | Effect of Dietary Fatty Acids on MicroRNA Expression Related to Metabolic Disorders and Inflammation in Human and Animal Trials. | 2021 | Details |
A03255 | 34069390 | Cells | Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers. | 2021 | Details |
A03257 | 34069012 | Int J Environ Res Public Health | Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. | 2021 | Details |
A03264 | 34065978 | Nutrients | PNPLA3 Genotype, Arachidonic Acid Intake, and Unsaturated Fat Intake Influences Liver Fibrosis in Hispanic Youth with Obesity. | 2021 | Details |
A03268 | 34065241 | Biology (Basel) | Treating the Metabolic Syndrome by Fecal Transplantation-Current Status. | 2021 | Details |
A03270 | 34065140 | Children (Basel) | Update on Metabolic Bariatric Surgery for Morbidly Obese Adolescents. | 2021 | Details |
A03271 | 34065108 | Int J Mol Sci | Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC. | 2021 | Details |
A03277 | 34064337 | J Clin Med | Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity. | 2021 | Details |
A03279 | 34063472 | Int J Mol Sci | The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A03280 | 34062716 | Int J Mol Sci | Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. | 2021 | Details |
A03281 | 34062584 | Dtsch Med Wochenschr | [Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease]. | 2021 | Details |
A03285 | 34060951 | Endocr Res | AST-120 Treatment Alters the Gut Microbiota Composition and Suppresses Hepatic Triglyceride Levels in Obese Mice. | 2021 | Details |
A03287 | 34060475 | J Endocrinol | DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice. | 2021 | Details |
A03288 | 34059777 | Eur J Clin Nutr | Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK Biobank. | 2021 | Details |
A03293 | 34058074 | FEBS J | Role of Mcpip1 in obesity-induced hepatic steatosis as determined by myeloid and liver-specific conditional knockouts. | 2021 | Details |
A03299 | 34054728 | Front Endocrinol (Lausanne) | Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study. | 2021 | Details |
A03304 | 34051210 | Biochem Pharmacol | The controversy on the beneficial effect of phytoestrogens in diabetic treatment in postmenopausal women. | 2021 | Details |
A03329 | 34043121 | Dig Dis Sci | Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention. | 2021 | Details |
A03330 | 34041467 | JHEP Rep | A nationwide population-based prospective study of cirrhosis in Iceland. | 2021 | Details |
A03332 | 34040583 | Front Endocrinol (Lausanne) | Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. | 2021 | Details |
A03334 | 34040322 | World J Gastroenterol | Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. | 2021 | Details |
A03335 | 34039490 | J Hepatol | The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. | 2021 | Details |
A03339 | 34036255 | JHEP Rep | Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past. | 2021 | Details |
A03349 | 34032283 | Eur J Clin Invest | Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. | 2021 | Details |
A03354 | 34031327 | Med J Malaysia | Liver fibrosis associated with adipose tissue and liver inflammation in an obesity model. | 2021 | Details |
A03355 | 34031143 | Diabetes Care | The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. | 2021 | Details |
A03357 | 34029949 | Biomed Pharmacother | The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model. | 2021 | Details |
A03358 | 34029162 | Am J Physiol Endocrinol Metab | β2-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states. | 2021 | Details |
A03359 | 34028830 | Med J Aust | Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study. | 2021 | Details |
A03361 | 34027933 | Minerva Gastroenterol (Torino) | The role of elastography in non-alcoholic fatty liver disease. | 2021 | Details |
A03362 | 34027591 | Dig Dis Sci | Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. | 2021 | Details |